LLY

Eli Lilly & Co
D

LLY

819.15
USD
-2.05
(-0.25%)
Market Open
Volume
70,299
EPS
23
Div Yield
0.66
P/E
70
Market Cap
735,300,456,513
OverviewSignalsIdeasNews
Signals
Moustafa El khaldy
Moustafa El khaldy
2 weeks ago
buy
LLY
LLY@823.59
2025-03-12 08:30
LLY@823.59 Chart
Profit
-24.50
Moustafa El khaldy
Moustafa El khaldy
1 month ago
buy
LLY
LLY@844.23
2025-02-17 11:21
LLY@844.23 Chart
Profit
3,513.00
More
Related Instruments
AMGN
AMGN
1.97
(0.64%)
306.61 USD
BMY
BMY
0.650
(1.10%)
59.540 USD
GSK
GSK
0.225
(0.58%)
38.740 USD
JNJ
JNJ
0.780
(0.48%)
163.150 USD
MRK
MRK
1.850
(2.11%)
87.985 USD
NVS
NVS
0.120
(0.11%)
111.530 USD
PFE
PFE
-0.055
(-0.22%)
24.960 USD
SNY
SNY
0.880
(1.60%)
55.760 USD
More
News
Novo Nordisk Shares Fall as Trial Results Disappoint

Novo Nordisk Shares Fall as Trial Results Disappoint

3 months ago
Stocks News
Treasury Yields Decline as Market Anticipates Fed Rate Cuts

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

7 months ago
Economy News
Roche’s Obesity Drug Puts Novo Nordisk and Eli Lilly on Alert

Roche’s Obesity Drug Puts Novo Nordisk and Eli Lilly on Alert

8 months ago
Stocks News
Novo Nordisk Surges in Profit and Sales

Novo Nordisk Surges in Profit and Sales

10 months ago
Stocks News
Biotech’s Top Performers Offer Solid Diversification Options

Biotech’s Top Performers Offer Solid Diversification Options

1 year ago
Stocks News
More

Title: Eli Lilly & Co

Sector: Healthcare
Industry: Drug Manufacturers - General
Eli Lilly and Company researches, develops, manufactures, and sells pharmaceutical products for humans and animals. This American multinational pharmaceutical firm has its company headquarters in Indianapolis, Indiana. It also has branch locations in 18 countries around the world. Its products find their way into markets in roughly 125 countries globally. Some of the firm’s marquee pharmaceutical brands include the clinical depression drug Prozac and the antipsychotic medication Zyprexa. The company has been ranked in the top 150 firms of the Fortune 500 list of top American companies by revenue.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.